Rethinking the role of biomarkers for operable non-small cell lung carcinoma: an effective collaboration with artificial intelligence algorithms

por Conde, Esther, Hernandez, Susana, Lopez-Rios, Fernando
Publicado 2022

Cellular pathology in the COVID-19 era: a European perspective on maintaining quality and safety

por Gosney, John R, Hofman, Paul, Troncone, Giancarlo, Lopez-Rios, Fernando
Publicado 2021

Immune Checkpoint Inhibitors in Urothelial Carcinoma: Recommendations for Practical Approaches to PD-L1 and Other Potential Predictive Biomarker Testing

por Lopez-Beltran, Antonio, López-Rios, Fernando, Montironi, Rodolfo, Wildsmith, Sophie, Eckstein, Markus
Publicado 2021

Implementing TMB measurement in clinical practice: considerations on assay requirements

por Büttner, Reinhard, Longshore, John W, López-Ríos, Fernando, Merkelbach-Bruse, Sabine, Normanno, Nicola, Rouleau, Etienne, Penault-Llorca, Frédérique
Publicado 2019

Treating KRAS-mutant NSCLC: latest evidence and clinical consequences

por Garrido, Pilar, Olmedo, María Eugenia, Gómez, Ana, Paz Ares, Luis, López-Ríos, Fernando, Rosa-Rosa, Juan Manuel, Palacios, José
Publicado 2017

A narrative review of methods for the identification of ALK fusions in patients with non-small cell lung carcinoma

por Hernandez, Susana, Conde, Esther, Alonso, Marta, Illarramendi, Adrian, Bote de Cabo, Helena, Zugazagoitia, Jon, Paz-Ares, Luis, Lopez-Rios, Fernando
Publicado 2023

HER2/neu testing for anti-HER2-based therapies in patients with unresectable and/or metastatic gastric cancer

por Gómez-Martin, Carlos, Garralda, Elena, Echarri, M José, Ballesteros, Anabel, Arcediano, Alberto, Rodríguez-Peralto, José Luis, Hidalgo, Manuel, López-Ríos, Fernando
Publicado 2012

EML4-ALK testing in non-small cell carcinomas of the lung: a review with recommendations

por Thunnissen, Erik, Bubendorf, Lukas, Dietel, Manfred, Elmberger, Göran, Kerr, Keith, Lopez-Rios, Fernando, Moch, Holger, Olszewski, Wlodzimierz, Pauwels, Patrick, Penault-Llorca, Frédérique, Rossi, Giulio
Publicado 2012

Hybridization for human epidermal growth factor receptor 2 testing in gastric carcinoma: a comparison of fluorescence in-situ hybridization with a novel fully automated dual-colour...

por García-García, Elena, Gómez-Martín, Carlos, Angulo, Bárbara, Conde, Esther, Suárez-Gauthier, Ana, Adrados, Magdalena, Perna, Cristian, Rodríguez-Peralto, José Luis, Hidalgo, Manuel, López-Ríos, Fernando
Publicado 2011

A Comparison of EGFR Mutation Testing Methods in Lung Carcinoma: Direct Sequencing, Real-time PCR and Immunohistochemistry

por Angulo, Bárbara, Conde, Esther, Suárez-Gauthier, Ana, Plaza, Carlos, Martínez, Rebeca, Redondo, Pilar, Izquierdo, Elisa, Rubio-Viqueira, Belén, Paz-Ares, Luis, Hidalgo, Manuel, López-Ríos, Fernando
Publicado 2012

Comparison of Testing Methods for the Detection of BRAF V600E Mutations in Malignant Melanoma: Pre-Approval Validation Study of the Companion Diagnostic Test for Vemurafenib

por Lopez-Rios, Fernando, Angulo, Barbara, Gomez, Belen, Mair, Debbie, Martinez, Rebeca, Conde, Esther, Shieh, Felice, Vaks, Jeffrey, Langland, Rachel, Lawrence, H. Jeffrey, de Castro, David Gonzalez
Publicado 2013

ALK IHC and FISH discordant results in patients with NSCLC and treatment response: for discussion of the question—to treat or not to treat?

por Cabillic, Florian, Hofman, Paul, Ilie, Marius, Peled, Nir, Hochmair, Maximilian, Dietel, Manfred, Von Laffert, Maximilian, Gosney, John R, Lopez-Rios, Fernando, Erb, Gilles, Schalles, Uwe, Barlesi, Fabrice
Publicado 2018

Comparison of molecular testing methods for the detection of EGFR mutations in formalin-fixed paraffin-embedded tissue specimens of non-small cell lung cancer

por Lopez-Rios, Fernando, Angulo, Barbara, Gomez, Belen, Mair, Debbie, Martinez, Rebeca, Conde, Esther, Shieh, Felice, Tsai, Julie, Vaks, Jeffrey, Current, Robert, Lawrence, H Jeffrey, Gonzalez de Castro, David
Publicado 2013

Molecular effects of lapatinib in patients with HER2 positive ductal carcinoma in situ

por Estévez, Laura G, Suarez-Gauthier, Ana, García, Elena, Miró, Cristina, Calvo, Isabel, Fernández-Abad, María, Herrero, Mercedes, Marcos, Manuel, Márquez, Cristina, Lopez Ríos, Fernando, Perea, Sofía, Hidalgo, Manuel
Publicado 2014

Testing for ROS1 in non-small cell lung cancer: a review with recommendations

por Bubendorf, Lukas, Büttner, Reinhard, Al-Dayel, Fouad, Dietel, Manfred, Elmberger, Göran, Kerr, Keith, López-Ríos, Fernando, Marchetti, Antonio, Öz, Büge, Pauwels, Patrick, Penault-Llorca, Frédérique, Rossi, Giulio, Ryška, Aleš, Thunnissen, Erik
Publicado 2016

Diagnostic procedures for non-small-cell lung cancer (NSCLC): recommendations of the European Expert Group

por Dietel, Manfred, Bubendorf, Lukas, Dingemans, Anne-Marie C, Dooms, Christophe, Elmberger, Göran, García, Rosa Calero, Kerr, Keith M, Lim, Eric, López-Ríos, Fernando, Thunnissen, Erik, Van Schil, Paul E, von Laffert, Maximilian
Publicado 2016

PDGFRα/β and VEGFR2 polymorphisms in colorectal cancer: incidence and implications in clinical outcome

por Estevez-Garcia, Purificacion, Castaño, Angel, Martin, Ana C, Lopez-Rios, Fernando, Iglesias, Joaquin, Muñoz-Galván, Sandra, Lopez-Calderero, Iker, Molina-Pinelo, Sonia, Pastor, Maria D, Carnero, Amancio, Paz-Ares, Luis, Garcia-Carbonero, Rocio
Publicado 2012

Immunotherapy Moves to the Early-Stage Setting in Non-Small Cell Lung Cancer: Emerging Evidence and the Role of Biomarkers

por Mielgo-Rubio, Xabier, Calvo, Virginia, Luna, Javier, Remon, Jordi, Martín, Margarita, Berraondo, Pedro, Jarabo, José Ramón, Higuera, Oliver, Conde, Esther, De Castro, Javier, Provencio, Mariano, Hernando Trancho, Florentino, López-Ríos, Fernando, Couñago, Felipe
Publicado 2020

The Use of P63 Immunohistochemistry for the Identification of Squamous Cell Carcinoma of the Lung

por Conde, Esther, Angulo, Bárbara, Redondo, Pilar, Toldos, Oscar, García-García, Elena, Suárez-Gauthier, Ana, Rubio-Viqueira, Belén, Marrón, Carmen, García-Luján, Ricardo, Sánchez-Céspedes, Montse, López-Encuentra, Angel, Paz-Ares, Luis, López-Ríos, Fernando
Publicado 2010

FGFR1 and FGFR4 oncogenicity depends on n-cadherin and their co-expression may predict FGFR-targeted therapy efficacy

por Quintanal-Villalonga, Álvaro, Ferrer, Irene, Guruceaga, Elizabeth, Cirauqui, Cristina, Marrugal, Ángela, Ojeda, Laura, García, Santiago, Zugazagoitia, Jon, Muñoz-Galván, Sandra, Lopez-Rios, Fernando, Montuenga, Luis, Vicent, Silvestre, Molina-Pinelo, Sonia, Carnero, Amancio, Paz-Ares, Luis
Publicado 2020